Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancerJ.-Y. Douillard, R. Sidhu, Salvatore Siena et al.|Annals of Oncology|2014Cited by 603
Germline-focussed analysis of tumour-only sequencing: recommendations from the ESMO Precision Medicine Working GroupClare Turnbull, Malavika Vivek, S. Jezdic et al.|Annals of Oncology|2019Cited by 237
Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trialJ Cassidy, L. Garrison, J.-Y. Douillard et al.|British Journal of Cancer|2006Cited by 125